Clinical Trial Update: De-escalation of Ticagrelor in Post PPCI [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on de-escalation of ticagrelor after primary percutaneous coronary intervention, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Assiut University | Conditions: Ticagrelor | Phase 1, Phase 2 | Status: UNKNOWN